Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CANINE NARCOLEPSY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 75 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sanlin-Pascual, RJ
      The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    2. Dauvilliers, Y; Neidhart, E; Lecendreux, M; Billiard, M; Tafti, M
      MAO-A and COMT polymorphisms and gene effects in narcolepsy

      MOLECULAR PSYCHIATRY
    3. Taheri, S; Gardiner, J; Hafizi, S; Murphy, K; Dakin, C; Seal, L; Small, C; Ghatei, M; Bloom, S
      Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats

      NEUROREPORT
    4. Mignot, E
      A commentary on the neurobiology of the hypocretin/orexin system

      NEUROPSYCHOPHARMACOLOGY
    5. Siegel, JM; Moore, R; Thannickal, T; Nienhuis, R
      A brief history of hypocretin/orexin and narcolepsy

      NEUROPSYCHOPHARMACOLOGY
    6. Overeem, S; Mignot, E; van Dijk, JG; Lammers, GJ
      Narcolepsy: Clinical features, new pathophysiologic insights, and future perspectives

      JOURNAL OF CLINICAL NEUROPHYSIOLOGY
    7. Vazquez, J; Baghdoyan, HA
      Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    8. Nishino, S; Fujiki, N; Ripley, B; Sakurai, E; Kato, M; Watanabe, T; Mignot, E; Yanai, K
      Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptics dogs

      NEUROSCIENCE LETTERS
    9. Wisor, JP; Nishino, S; Sora, I; Uhl, GH; Mignot, E; Edgar, DM
      Dopaminergic role in stimulant-induced wakefulness

      JOURNAL OF NEUROSCIENCE
    10. Gerashchenko, D; Kohls, MD; Greco, M; Waleh, NS; Salin-Pascual, R; Kilduff, TS; Lappi, DA; Shiromani, PJ
      Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat

      JOURNAL OF NEUROSCIENCE
    11. Hungs, M; Mignot, E
      Hypocretin/orexin, sleep and narcolepsy

      BIOESSAYS
    12. White, EC; De Lahunta, A
      Narcolepsy in a ram lamb

      VETERINARY RECORD
    13. Huang, ZL; Qu, WM; Li, WD; Mochizuki, T; Eguchi, N; Watanabe, T; Urade, Y; Hayaishi, O
      Arousal effect of orexin A depends on activation of hte histmic system

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    14. Krahn, LE; Black, JL; Silber, MH
      Narcolepsy: New understanding of irresistible sleep

      MAYO CLINIC PROCEEDINGS
    15. Gerashchenko, D; Salin-Pascual, R; Shiromani, PJ
      Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta

      BRAIN RESEARCH
    16. Guilleminault, C; Brooks, SN
      Excessive daytime sleepiness - A challenge for the practising neurologist

      BRAIN
    17. Sanford, LD; Silvestri, AJ; Ross, RJ; Morrison, AR
      Influence of fear conditioning on elicited ponto-geniculo-occipital waves and rapid eye movement sleep

      ARCHIVES ITALIENNES DE BIOLOGIE
    18. Mignot, E
      A hundred years of narcolepsy research

      ARCHIVES ITALIENNES DE BIOLOGIE
    19. Schapira, AHV
      The aetiology and management of sleep episodes in Parkinson's disease

      EUROPEAN JOURNAL OF NEUROLOGY
    20. Peyron, C; Faraco, J; Rogers, W; Ripley, B; Overeem, S; Charnay, Y; Nevsimalova, S; Aldrich, M; Reynolds, D; Albin, R; Li, R; Hungs, M; Pedrazzoli, M; Padigaru, M; Kucherlapati, M; Fan, J; Maki, R; Lammers, GJ; Bouras, C; Kucherlapati, R; Nishino, S; Mignot, E
      A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

      NATURE MEDICINE
    21. Samson, WK; Resch, ZT
      The hypocretin/orexin story

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    22. van den Pol, AN
      Narcolepsy: A neurodegenerative disease of the hypocretin system?

      NEURON
    23. Thannickal, TC; Moore, RY; Nienhuis, R; Ramanathan, L; Gulyani, S; Aldrich, M; Cornford, M; Siegel, JM
      Reduced number of hypocretin neurons in human narcolepsy

      NEURON
    24. Billiard, M; Dauvilliers, Y
      Narcolepsy: a key role for hypocretins

      M S-MEDECINE SCIENCES
    25. Sutcliffe, JG; de Lecea, L
      The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding

      JOURNAL OF NEUROSCIENCE RESEARCH
    26. Scammell, TE; Estabrooke, IV; McCarthy, MT; Chemelli, RM; Yanagisawa, M; Miller, MS; Saper, CB
      Hypothalamic arousal regions are activated during modafinil-induced wakefulness

      JOURNAL OF NEUROSCIENCE
    27. Bourgin, P; Huitron-Resendiz, S; Spier, AD; Fabre, V; Morte, B; Criado, JR; Sutcliffe, JG; Henriksen, SJ; de Lecea, L
      Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons

      JOURNAL OF NEUROSCIENCE
    28. Nishino, S; Riehl, J; Hong, J; Kwan, M; Reid, M; Mignot, E
      Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans

      NEUROSCIENCE RESEARCH
    29. Kilduff, TS; Peyron, C
      The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders

      TRENDS IN NEUROSCIENCES
    30. Miyagawa, T; Hohjoh, H; Honda, Y; Juji, T; Tokunaga, K
      Identification of a telomeric boundary of the HLA region with potential for predisposition to human narcolepsy

      IMMUNOGENETICS
    31. Becker, PM; Jamieson, AO; Jewel, CE; Bogan, RK; James, DS; Sutton, JT; Corser, B; Mayleben, DW; Bernard, SH; Dinner, DS; Emsellem, H; Knight, E; Erwin, CW; Krystal, AD; Radtke, RA; Farrow, S; Odynski, T; Pinto, J; Steljes, D; Feldman, NT; O'Brien, M; Fredrickson, PA; Kaplan, J; Lin, SC; Burger, C; Fry, JM; Guilleminault, C; Black, J; Green, PM; Schmitigal, L; Gross, PT; Dignan, S; Harsh, J; Hartwig, G; Haynes, JB; Hageman, M; Porter-Shirley, K; Hertz, G; Hirshkowitz, M; Moore, CA; Iyer, V; Mahowald, MM; Ullevig, C; Mitler, MM; Hayduk, R; Erman, MK; Pascualy, R; Stolz, S; Parman, D; Richter, RW; Gruenau, SP; Webster, JJ; Ristanovic, RK; Bergen, D; Kanner, A; Dyonzak, J; Rogers, AE; Aldrich, MS; Rosenberg, R; Richardson, T; Lee, J; Sahota, PK; Dexter, JD; Burger, RC; Sangal, RB; Sangal, JM; Belisle, C; Schmidt, HS; Parisot, PA; Schmidt-Nowara, WW; Jessup, C; Schwartz, JRL; Schwartz, ER; Veit, C; Blakely, L; Scrima, L; Miller, BR; Shettar, SM; May, RS; Wilkerson, KE; Stafford, C; Grogan, WA; Tearse, R; Thein, SG; Colontonio, L; Vern, BA; Mercer, PJ; Merritt, SL; Walsleben, JA; O'Malley, MB; Rapoport, DM; Winokur, A; Szuba, MD; Civil, RH; Dobbins, TW; Kribbs, NB; Laughton, WB; Nelson, MT; Wang, LX
      Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

      NEUROLOGY
    32. Bierbrauer, J; Heidenreich, T; Hilwerling, L; von Nessen, S; Fey, P; Kogel, P; Pflug, B; Dahmen, N
      Narcolepsy: remarkable progress

      NERVENARZT
    33. Chicurel, M
      The sandman's secrets

      NATURE
    34. Lu, XY; Bagnol, D; Burke, S; Akil, H; Watson, SJ
      Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting

      HORMONES AND BEHAVIOR
    35. Nakamura, T; Uramura, K; Nambu, T; Yada, T; Goto, K; Yanagisawa, M; Sakurai, T
      Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system

      BRAIN RESEARCH
    36. Riehl, J; Okura, M; Mignot, E; Nishino, S
      Inheritance of von Willebrand's disease in a colony of Doberman Pinschers

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    37. Wagner, JL; Storb, R; Storer, B; Mignot, E
      DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs

      TISSUE ANTIGENS
    38. Ostrander, EA; Giniger, E
      Let sleeping dogs lie?

      NATURE GENETICS
    39. Tobler, I
      Genetic approaches to sleep and sleep disorders - Introduction

      JOURNAL OF SLEEP RESEARCH
    40. Honda, K; Riehl, J; Mignot, E; Nishino, S
      Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep (vol 10, pg 3111, 1999)

      NEUROREPORT
    41. Honda, K; Riehl, J; Mignot, E; Nishino, S
      Dopamine D-3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep

      NEUROREPORT
    42. Aldrich, MS; Reynolds, PR
      Narcolepsy and the hypocretin receptor 2 gene

      NEURON
    43. Nishino, S; Mignot, E
      Drug treatment of patients with insomnia and excessive daytime sleepiness - Pharmacokinetic considerations

      CLINICAL PHARMACOKINETICS
    44. Wu, MF; Gulyani, SA; Yau, E; Mignot, E; Phan, B; Siegel, JM
      Locus coeruleus neurons: Cessation of activity during cataplexy

      NEUROSCIENCE
    45. Bourgin, P; Ahnaou, A; Laporte, AM; Hamon, M; Adrien, J
      Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors

      NEUROSCIENCE
    46. Chemelli, RM; Willie, JT; Sinton, CM; Elmquist, JK; Scammell, T; Lee, C; Richardson, JA; Williams, SC; Xiong, YM; Kisanuki, Y; Fitch, TE; Nakazato, M; Hammer, RE; Saper, CB; Yanagisawa, M
      Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation

      CELL
    47. Sebban, C; Zhang, XQ; Tesolin-Decros, B; Millan, MJ; Spedding, M
      Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

      BRITISH JOURNAL OF PHARMACOLOGY
    48. Nishino, S; Honda, K; Riehl, J; Okura, M; Mignot, E
      Neuronal activity in the cholinoceptive basal forebrain of freely moving narcoleptic dobermans

      NEUROREPORT
    49. CARLANDER B; TOUCHON J; BILLIARD M
      HYPERSOMNIA NARCOLEPSY (GELINEAUS-SYNDROME)

      La Presse medicale
    50. CHOO KL; GUILLEMINAULT C
      NARCOLEPSY AND IDIOPATHIC HYPERSOMNOLENCE

      Clinics in chest medicine
    51. CEDERBERG R; NISHINO S; DEMENT WC; MIGNOT E
      BREEDING HISTORY OF THE STANFORD COLONY OF NARCOLEPTIC DOGS

      Veterinary record
    52. BILLIARD M; CARLANDER B
      WAKE DISORDERS - PART 1 - PRIMARY WAKE DI SORDERS

      Revue neurologique
    53. SUDO Y; SUHARA T; HONDA Y; NAKAJIMA T; OKUBO Y; SUZUKI K; NAKASHIMA Y; YOSHIKAWA K; OKAUCHI T; SASAKI Y; MATSUSHITA M
      MUSCARINIC CHOLINERGIC RECEPTORS IN HUMAN NARCOLEPSY - A PET STUDY

      Neurology
    54. GUILLEMINAULT C; HEINZER R; MIGNOT E; BLACK J
      INVESTIGATIONS INTO THE NEUROLOGIC BASIS OF NARCOLEPSY

      Neurology
    55. RIEHL J; NISHINO S; CEDERBERG R; DEMENT WC; MIGNOT E
      DEVELOPMENT OF CATAPLEXY IN GENETICALLY NARCOLEPTIC DOBERMANS

      Experimental neurology
    56. NISHINO S; TAFTI M; SAMPATHKUMARAN R; DEMENT WC; MIGNOT E
      CIRCADIAN DISTRIBUTION OF REST ACTIVITY IN NARCOLEPTIC AND CONTROL DOGS - ASSESSMENT WITH AMBULATORY ACTIVITY MONITORING/

      Journal of sleep research
    57. LEONARD TO; LYDIC R
      PONTINE NITRIC-OXIDE MODULATES ACETYLCHOLINE-RELEASE, RAPID EYE-MOVEMENT SLEEP GENERATION, AND RESPIRATORY RATE

      The Journal of neuroscience
    58. TAFTI M; NISHINO S; LIAO W; DEMENT WC; MIGNOT E
      MESOPONTINE ORGANIZATION OF CHOLINERGIC AND CATECHOLAMINERGIC CELL GROUPS IN THE NORMAL AND NARCOLEPTIC DOG

      Journal of comparative neurology
    59. MACFARLANE JG; LIST SJ; MOLDOFSKY H; FIRNAU G; CHEN JJ; SZECHTMAN H; GARNETT S; NAHMIAS C
      DOPAMINE D2 RECEPTORS QUANTIFIED IN-VIVO IN HUMAN NARCOLEPSY

      Biological psychiatry
    60. MIGNOT E; KIMURA A; LATTERMANN A; LIN X; YASUNAGA S; MUELLERECKHARDT G; RATTAZZI C; LIN L; GUILLEMINAULT C; DEMENT WC; UNDERHILL P
      EXTENSIVE HLA CLASS-II STUDIES IN 58 NON-DRB1-ASTERISK-15 (DR2) NARCOLEPTIC PATIENTS WITH CATAPLEXY

      Tissue antigens
    61. SINGH SM; GEORGE CFP; OTT RN; RATTAZZI C; GUILLEMINAULT C; DEMENT WC; MIGNOT E
      IGH (MU-SWITCH AND GAMMA-1) REGION RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM IN HUMAN NARCOLEPSY

      Journal of clinical immunology
    62. STAEDT J; STOPPE G; KOGLER A; RIEMANN H; HAJAK G; RODENBECK A; MAYER G; STEINHOFF BJ; MUNZ DL; EMRICH D; RUTHER E
      [I-123] IBZM SPET ANALYSIS OF DOPAMINE D-2 RECEPTOR OCCUPANCY IN NARCOLEPTIC PATIENTS IN THE COURSE OF TREATMENT

      Biological psychiatry
    63. SHELTON J; NISHINO S; VAUGHT J; DEMENT WC; MIGNOT E
      COMPARATIVE EFFECTS OF MODAFINIL AND AMPHETAMINE ON DAYTIME SLEEPINESS AND CATAPLEXY OF NARCOLEPTIC DOGS

      Sleep
    64. RINNE JO; HUBLIN C; PARTINEN M; RUOTTINEN H; RUOTSALAINEN U; NAGREN K; LEHIKOINEN P; LAIHINEN A
      POSITRON EMISSION TOMOGRAPHY STUDY OF HUMAN NARCOLEPSY - NO INCREASE IN STRIATAL DOPAMINE D-2 RECEPTORS

      Neurology
    65. ROSS RJ; GRESCH PJ; BALL WA; SANFORD LD; MORRISON AR
      REM-SLEEP INHIBITION BY DESIPRAMINE - EVIDENCE FOR AN ALPHA-1-ADRENERGIC MECHANISM

      Brain research
    66. NAVARRO JF; TORTAJADA RE
      NARCOLEPSY

      Psicologia conductual
    67. NISHINO S; REID MS; DEMENT WC; MIGNOT E
      NEUROPHARMACOLOGY AND NEUROCHEMISTRY OF CANINE NARCOLEPSY

      Sleep
    68. ALDRICH MS; PROKOPOWICZ G; OCKERT K; HOLLINGSWORTH Z; PENNEY JB; ALBIN RL
      NEUROCHEMICAL STUDIES OF HUMAN NARCOLEPSY - ALPHA-ADRENERGIC RECEPTORAUTORADIOGRAPHY OF HUMAN NARCOLEPTIC BRAIN AND BRAIN-STEM

      Sleep
    69. HUBLIN C; LAUNES J; NIKKINEN P; PARTINEN M
      DOPAMINE D-2-RECEPTORS IN HUMAN NARCOLEPSY - A SPECT STUDY WITH I-123IBZM

      Acta neurologica Scandinavica
    70. HOHAGEN F; MAYER G; MENCHE A; RIEMANN D; VOLK S; MEIEREWERT KH; BERGER M
      TREATMENT OF NARCOLEPSY CATAPLEXY SYNDROME WITH THE NEW SELECTIVE ANDREVERSIBLE MAO-A INHIBITOR BROFAROMINE - A PILOT-STUDY

      Journal of sleep research
    71. LUNN DP; CUDDON PA; SHAFTOE S; ARCHER RM
      FAMILIAL OCCURRENCE OF NARCOLEPSY IN MINIATURE HORSES

      Equine veterinary journal
    72. ALDRICH MS
      THE NEUROBIOLOGY OF NARCOLEPSY CATAPLEXY

      Progress in neurobiology
    73. ALLEN D; NUTT D
      COEXISTENCE OF PANIC DISORDER AND SLEEP PARALYSIS

      JOURNAL OF PSYCHOPHARMACOLOGY
    74. NISHINO S; ARRIGONI J; SHELTON J; DEMENT WC; MIGNOT E
      DESMETHYL METABOLITES OF SEROTONERGIC UPTAKE INHIBITORS ARE MORE POTENT FOR SUPPRESSING CANINE CATAPLEXY THAN THEIR PARENT COMPOUNDS

      Sleep
    75. MITLER MM; HAJDUKOVIC R; ERMAN MK
      TREATMENT OF NARCOLEPSY WITH METHAMPHETAMINE

      Sleep


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 07:05:59